Differential expression of PACAP receptors in postnatal rat brain

Arimura, 1991, Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes, Endocrinology, 129, 2787, 10.1210/endo-129-5-2787

Atlasz, 2008, PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration, J. Mol. Neurosci., 36, 97, 10.1007/s12031-008-9059-5

Babai, 2006, Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina, Ann. N. Y. Acad. Sci., 1070, 149, 10.1196/annals.1317.003

Bremner, 2002, Reduced volume of orbitofrontal cortex in major depression, Biol. Psychiatry, 51, 273, 10.1016/S0006-3223(01)01336-1

Chen, 2006, Neuroprotection by endogenous and exogenous PACAP following stroke, Regul. Pept., 137, 4, 10.1016/j.regpep.2006.06.016

Daniel, 2001, J. Biol. Chem., 276, 12938, 10.1074/jbc.M009941200

Dautzenberg, 1999, N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants, J. Neuroendocrinol., 11, 941, 10.1046/j.1365-2826.1999.00411.x

Dickson, 2009, VPAC and PAC receptors: From ligands to function, Pharmacol. Ther., 121, 294, 10.1016/j.pharmthera.2008.11.006

Dmitrieva, 1977, Dimensions of the hippocampus, memory, and learning in the ontogenesis of rats, Neurosci. Behav. Physiol., 8, 321, 10.1007/BF01182909

Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol. Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013

Duman, 1997, A molecular and cellular theory of depression, Arch. Gen. Psychiatry, 54, 597, 10.1001/archpsyc.1997.01830190015002

Hammack, 2009, Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior, Psychoneuroendocrinology, 34, 833, 10.1016/j.psyneuen.2008.12.013

Hashimoto, 2001, Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP), Proc. Natl Acad. Sci. USA, 98, 13355, 10.1073/pnas.231094498

Hashimoto, 2007, Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia, Mol. Psychiatry, 12, 1026, 10.1038/sj.mp.4001982

Jarrard, 1993, On the role of the hippocampus in learning and memory in the rat, Behav. Neurol. Biol., 60, 9, 10.1016/0163-1047(93)90664-4

Journot, 1994, The PACAP receptor: generation by alternative splicing of functional diversity among G protein-coupled receptors in nerve cells, Semin. Cell Biol., 5, 263, 10.1006/scel.1994.1032

Kamnasaran, 2003, Genetic analysis of psychiatric disorders associated with human chromosome 18, Clin. Invest. Med., 26, 285

Kudielka, 2005, Sex differences in HPA axis responses to stress: a review, Biol. Psychol., 69, 113, 10.1016/j.biopsycho.2004.11.009

Li, 2000, Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads, Endocrinology, 141, 3723, 10.1210/en.141.10.3723

Miyata, 1989, Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells, Biochem. Biophys. Res. Commun., 164, 567, 10.1016/0006-291X(89)91757-9

Nachkebiia, 1985, Effect of functional elimination of the hippocampus on learning and memory, Fiziol. Zh., 31, 385

Nguyen, 1993, Structural characterization of PACAP receptors on rat liver plasma membranes, Am. J. Physiol., 265, G811

O’Hearn, 2008, Neurodevelopment and executive function in autism, Dev. Psychopathol., 20, 1103, 10.1017/S0954579408000527

Ohtaki, 2008, Role of PACAP in ischemic neural death, J. Mol. Neurosci., 36, 16, 10.1007/s12031-008-9077-3

Onoue, 2002, The neuropeptide PACAP attenuates beta-amyloid (1–42)-induced toxicity in PC12 cells, Peptides, 23, 1471, 10.1016/S0196-9781(02)00085-2

Pilzer, 2006, VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new neuroprotection target, Peptides, 27, 2867, 10.1016/j.peptides.2006.06.007

Rangon, 2005, VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice, J. Pharmacol. Exp. Ther., 314, 745, 10.1124/jpet.105.086405

Reglodi, 2000, Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat, Stroke, 31, 1411, 10.1161/01.STR.31.6.1411

Reichenstein, 2008, Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action, J. Mol. Neurosci., 36, 330, 10.1007/s12031-008-9116-0

Sanches, 2008, Neurodevelopmental basis of bipolar disorder: a critical appraisal, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1617, 10.1016/j.pnpbp.2008.04.017

Sheline, 2003, Untreated depression and hippocampal volume loss, Am. J. Psychiatry, 160, 1516, 10.1176/appi.ajp.160.8.1516

Shen, 1994, The hippocampus: a biological model for studying learning and memory, Prog. Neurobiol., 44, 485, 10.1016/0301-0082(94)90008-6

Sheward, 1996, Expression of pituitary adenylate cyclase activating polypeptide receptors in the early mouse embryo as assessed by reverse transcription polymerase chain reaction and in situ hybridisation, Neurosci. Lett., 216, 45, 10.1016/0304-3940(96)13002-0

Shioda, 2006, Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment, Ann. N. Y. Acad. Sci., 1070, 550, 10.1196/annals.1317.080

Spengler, 1993, Differential signal transduction by five splice variants of the PACAP receptor, Nature, 365, 170, 10.1038/365170a0

Stumm, 2007, Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage, J. Neurochem., 103, 1666, 10.1111/j.1471-4159.2007.04895.x

Tatsuno, 1990, Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes, Biochem. Biophys. Res. Commun., 168, 1027, 10.1016/0006-291X(90)91132-C

Usdin, 1994, Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions, Endocrinology, 135, 2662, 10.1210/en.135.6.2662

Vaudry, 1999, Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development, Proc. Natl Acad. Sci. USA, 96, 9415, 10.1073/pnas.96.16.9415

Vaudry, 2000, Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions, Pharmacol. Rev., 52, 269

Vaudry, 2009, Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery, Pharmacol. Rev., 61, 283, 10.1124/pr.109.001370

Vita, 1997, Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature, Schizophr. Res., 23, 25, 10.1016/S0920-9964(96)00085-0

Waschek, 2002, Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration, Dev. Neurosci., 24, 14, 10.1159/000064942

Waschek, 1998, Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis, Proc. Natl Acad. Sci. USA, 95, 9602, 10.1073/pnas.95.16.9602

Watanabe, 2006, Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C, J. Neurosci. Res., 84, 1645, 10.1002/jnr.21065

Zhou, 1999, Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage, Neuroscience, 93, 375, 10.1016/S0306-4522(99)00108-6

Zhou, 2000, Ontogeny of PACAP receptor and its splice variants in the rat brain, Ann. N. Y. Acad. Sci., 921, 375, 10.1111/j.1749-6632.2000.tb06998.x